Spots Global Cancer Trial Database for refractory b cell acute lymphoblastic leukemia
Every month we try and update this database with for refractory b cell acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) | NCT04404660 | Relapsed or Ref... | AUTO1 | 18 Years - | Autolus Limited | |
Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia | NCT03599375 | Leukemia, B-Cel... | CD19-targeted C... | 14 Years - 75 Years | The First Hospital of Jilin University | |
Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia | NCT03599375 | Leukemia, B-Cel... | CD19-targeted C... | 14 Years - 75 Years | The First Hospital of Jilin University | |
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) | NCT06173518 | Relapsed or Ref... Relapsed or Ref... | AUTO1 | 0 Years - 18 Years | Autolus Limited |